Guidelines for the Prevention and Management of Graft-versus-Host Disease after Cord Blood Transplantation

American Society for Transplantation and Cellular Therapy Cord Blood Special Interest Group

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

The incidence of graft-versus-host disease (GVHD) after cord blood (CB) transplantation (CBT) is lower than expected given the marked degree of human leukocyte antigen (HLA)-mismatch of CB grafts. While the exact mechanism that underlies this biology remains unclear, it is hypothesized to be due to the low number of mostly immature T-cells infused as part of the graft1,2, and increased tolerance of CB-derived lymphocytes induced by the state of pregnancy. Nevertheless, acute GVHD (aGVHD) is a significant complication of CBT. In contrast, the incidence of chronic GVHD (cGVHD) following CBT is lower than what is observed following matched related or unrelated donor HSC transplantation (HSCT)3-6. This review outlines the guidelines for the prevention and management of acute and chronic GVHD following CBT.

Original languageEnglish (US)
Pages (from-to)540-544
Number of pages5
JournalTransplantation and Cellular Therapy
Volume27
Issue number7
DOIs
StatePublished - Jul 1 2021

Bibliographical note

Publisher Copyright:
© 2021 The American Society for Transplantation and Cellular Therapy

Keywords

  • Cord blood transplant
  • Graft-versus-host disease

Fingerprint

Dive into the research topics of 'Guidelines for the Prevention and Management of Graft-versus-Host Disease after Cord Blood Transplantation'. Together they form a unique fingerprint.

Cite this